Callan JMB Files S-1 for Hexstone Resale, Seeks $25M in Future Capital

TL;DR

**CJMB's S-1 is a mixed bag: immediate dilution risk from Hexstone's resale, but a $25M capital lifeline could fuel its niche cold chain growth.**

AI Summary

CALLAN JMB INC. (CJMB) is filing an S-1 for the proposed resale of up to 6,000,000 shares of common stock by Hexstone Capital, LLC, a selling stockholder. The company will not receive any proceeds from this specific resale but anticipates receiving up to $25,000,000 in aggregate gross proceeds from future sales of common stock to Hexstone under a Purchase Agreement dated July 24, 2025. CJMB operates as a vertically integrated logistics and fulfillment company, specializing in thermal management solutions for the life sciences industry, utilizing proprietary packaging and its 'Sentry' cloud-based logistics platform. The company's stock trades on The Nasdaq Capital Market under the symbol 'CJMB', with a last reported sales price of $4.76 per share on August 22, 2025. CJMB is an emerging growth company, taking advantage of reduced reporting requirements. Key business changes include the development of its Ship2Q ultraviolet disinfection process and the Sentry system, which integrates GPS and temperature diagnostics for cold chain logistics.

Why It Matters

This S-1 filing signals Callan JMB's intent to leverage an existing equity line of credit with Hexstone Capital, potentially injecting up to $25,000,000 into the company, which is crucial for its growth in the competitive life sciences logistics sector. For investors, while the immediate offering is a resale by Hexstone, the potential for future capital raises through the Purchase Agreement could dilute existing shareholders but also fund expansion. Employees and customers could benefit from enhanced operational capabilities and continued innovation in thermal management solutions, particularly with the Ship2Q and Sentry systems. The broader market will watch how CJMB, as an emerging growth company, navigates capital raises and competes against established logistics providers in the specialized cold chain segment.

Risk Assessment

Risk Level: medium — The filing indicates a 'high degree of risk' for investors, as stated on page 14. While the company is not directly selling shares in this specific offering, the potential for Hexstone to sell up to 6,000,000 shares could create downward pressure on the stock. Furthermore, the company's reliance on future sales to Hexstone for up to $25,000,000 in proceeds introduces uncertainty regarding the timing and pricing of these capital infusions.

Analyst Insight

Investors should closely monitor the volume and pricing of Hexstone's resales to gauge potential dilution and market impact. Consider the long-term growth prospects of Callan JMB's specialized cold chain logistics business, weighing the potential $25,000,000 capital injection against the risks outlined in the 'Risk Factors' section, particularly regarding market competition and the ability to achieve profitability.

Key Numbers

• 6,000,000 — Shares of Common Stock (Maximum shares Hexstone Capital, LLC may resell)
• $25,000,000 — Potential Gross Proceeds (Amount Callan JMB may receive from future sales to Hexstone)
• $0.001 — Par Value per Share (Par value of Callan JMB's Common Stock)
• 95% — Purchase Price Percentage (Percentage of lowest VWAP at which Hexstone may purchase shares)
• $4.76 — Last Reported Stock Price (CJMB's closing price on Nasdaq on August 22, 2025)
• July 24, 2025 — ELOC Purchase Agreement Date (Date of the agreement between Callan JMB and Hexstone Capital)
• August 25, 2025 — S-1 Filing Date (Date the S-1 registration statement was filed with the SEC)
• $7,500,000 — Minimum Sales Threshold (Amount of shares Hexstone must sell to avoid Termination Shares issuance)

Key Players & Entities

• CALLAN JMB INC. (company) — Registrant and vertically integrated logistics company
• Hexstone Capital, LLC (company) — Selling Stockholder and 'underwriter' for the resale
• Mr. Wayne Williams (person) — Chief Executive Officer of Callan JMB Inc.
• Ross David Carmel, Esq. (person) — Legal counsel from Sichenzia Ross Ference Carmel LLP
• Barry P. Biggar, Esq (person) — Legal counsel from Sichenzia Ross Ference Carmel LLP
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for the S-1 filing
• $25,000,000 (dollar_amount) — Aggregate gross proceeds Callan JMB may receive from Hexstone
• $4.76 (dollar_amount) — Last reported sales price of CJMB Common Stock on August 22, 2025
• Nasdaq Capital Market (company) — Exchange where CJMB Common Stock is traded
• Nevada (regulator) — State of incorporation for Callan JMB Inc.

FAQ

Risk Factors

• Hexstone Capital Purchase Agreement Risks [medium — financial]: The company may receive up to $25,000,000 from future sales to Hexstone Capital under a Purchase Agreement dated July 24, 2025. However, the current S-1 filing pertains to the resale of 6,000,000 shares by Hexstone, from which Callan JMB will receive no proceeds. The terms of the purchase agreement, including the percentage of the lowest VWAP (95%) at which Hexstone may purchase shares, could impact the effective price Callan JMB receives in future transactions.
• Stock Price Volatility [medium — market]: The company's stock trades on the Nasdaq Capital Market under the symbol 'CJMB'. The last reported sales price was $4.76 per share on August 22, 2025. As an emerging growth company, CJMB may be subject to higher stock price volatility compared to more established companies, influenced by market sentiment and the success of its growth initiatives.
• Dependence on Proprietary Technology [high — operational]: Callan JMB's business relies on its proprietary packaging and 'Sentry' cloud-based logistics platform for thermal management solutions in the life sciences industry. The success of its Ship2Q ultraviolet disinfection process and the Sentry system, which integrates GPS and temperature diagnostics, is critical. Any failure or obsolescence of these technologies could significantly impact operations.

Industry Context

Callan JMB Inc. operates in the logistics and fulfillment sector, with a specific focus on thermal management solutions for the life sciences industry. This niche requires specialized packaging and advanced tracking technologies to maintain product integrity, particularly for temperature-sensitive goods. The company leverages proprietary technology and a cloud-based platform to address these stringent requirements, positioning itself within a growing market driven by the demand for reliable cold chain logistics.

Regulatory Implications

As a publicly traded company filing an S-1, Callan JMB Inc. is subject to SEC regulations and disclosure requirements. The filing itself is a regulatory step to facilitate the resale of shares and outline future capital raising activities. As an emerging growth company, it benefits from certain regulatory accommodations, but must still adhere to ongoing compliance obligations.

What Investors Should Do

1. Review the terms of the Hexstone Capital Purchase Agreement
2. Assess the competitive landscape for cold chain logistics in life sciences
3. Monitor the resale of shares by Hexstone Capital, LLC

Key Dates

• 2025-07-24: ELOC Purchase Agreement Signed — Established the framework for future capital raises up to $25,000,000 from Hexstone Capital, LLC.
• 2025-08-22: Last Reported Stock Price — Indicates the current market valuation of Callan JMB Inc. at $4.76 per share.
• 2025-08-25: S-1 Filing Date — Initiated the registration process for the resale of 6,000,000 shares by Hexstone Capital, LLC, and disclosed future potential capital raise terms.

Glossary

S-1 Filing

A registration statement filed with the U.S. Securities and Exchange Commission (SEC) by companies planning to offer securities to the public. It contains detailed information about the company's business, financial condition, and the securities being offered. (This filing by Callan JMB Inc. pertains to the resale of shares by a selling stockholder and outlines future purchase agreements.)

Selling Stockholder

An existing shareholder who is selling their shares in a public offering, rather than the company itself selling newly issued shares. (Hexstone Capital, LLC is the selling stockholder in this S-1 filing, offering up to 6,000,000 shares.)

Emerging Growth Company

A designation under the JOBS Act for companies with less than $1.235 billion in annual gross revenue (as of 2019). These companies are allowed to take advantage of reduced reporting requirements. (Callan JMB Inc. is an emerging growth company, which impacts the level of detail and scrutiny in its SEC filings.)

VWAP

Volume Weighted Average Price. It is the average price of a security over a given period, weighted by the trading volume at each price level. (Hexstone Capital may purchase shares from Callan JMB at 95% of the lowest VWAP, which is a key term in their purchase agreement.)

Prospectus

A legal document required by securities regulators that provides details about an investment offering for sale to the public. It includes information about the company, its management, financial statements, and the risks involved. (This S-1 filing includes a prospectus detailing the resale of shares and future purchase agreements.)

Year-Over-Year Comparison

This S-1 filing focuses on the resale of shares by Hexstone Capital, LLC and outlines a future purchase agreement for potential capital raises up to $25,000,000. Specific comparative financial metrics against a prior filing are not detailed within the provided context. However, the filing highlights the company's operational focus on thermal management solutions and its proprietary 'Sentry' platform, indicating ongoing business development efforts.

Key Financial Figures

• $0.001 — of our common stock with a par value of $0.001 per share (the "Common Stock"), which m
• $7,500,000 — suable to Hexstone if we sell less than $7,500,000 worth of shares of Common Stock to Hexs
• $25,000,000 — Hexstone. However, we may receive up to $25,000,000 in aggregate gross proceeds under the P
• $4.76 — Stock on Nasdaq on August 22, 2025 was $4.76 per share. We are an emerging growth

Filing Documents

• forms-1.htm (S-1) — 2442KB
• ex5-1.htm (EX-5.1) — 12KB
• ex21-1.htm (EX-21.1) — 4KB
• ex23-1.htm (EX-23.1) — 4KB
• ex107.htm (EX-FILING FEES) — 27KB
• forms-1_001.jpg (GRAPHIC) — 12KB
• forms-1_002.jpg (GRAPHIC) — 34KB
• forms-1_003.jpg (GRAPHIC) — 17KB
• ex5-1_001.jpg (GRAPHIC) — 29KB
• 0001641172-25-025422.txt ( ) — 9895KB
• cjmb-20250630.xsd (EX-101.SCH) — 54KB
• cjmb-20250630_cal.xml (EX-101.CAL) — 84KB
• cjmb-20250630_def.xml (EX-101.DEF) — 246KB
• cjmb-20250630_lab.xml (EX-101.LAB) — 441KB
• cjmb-20250630_pre.xml (EX-101.PRE) — 375KB
• forms-1_htm.xml (XML) — 1656KB
• ex107_htm.xml (XML) — 5KB

RISK FACTORS

RISK FACTORS 14 THE HEXSTONE TRANSACTION 35

USE OF PROCEEDS

USE OF PROCEEDS 38 MARKET INFORMATION FOR SECURITIES AND DIVIDEND POLICY 39

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 40

BUSINESS

BUSINESS 49 MANAGEMENT 56

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 63 CURRENT RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 73

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 75

DESCRIPTION OF SECURITIES

DESCRIPTION OF SECURITIES 76 MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS 79 SELLING STOCKHOLDER 81 PLAN OF DISTRIBUTION 82 LEGAL MATTERS 83 EXPERTS 83 WHERE YOU CAN FIND MORE INFORMATION 83

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS F-1 You should rely only on the information contained in this prospectus or any amendment or supplement to this prospectus. This prospectus is an offer to sell only the securities offered hereby, but only under the circumstances and in jurisdictions where it is lawful to do so. Neither we nor the Selling Stockholder have authorized anyone to provide you with information different from that contained in this prospectus or any amendment or supplement to this prospectus. Neither we nor the Selling Stockholder take any responsibility for, or can provide any assurance as to the reliability of, any information other than the information in this prospectus or any amendment or supplement to this prospectus. The information in this prospectus or any amendment or supplement to this prospectus is accurate only as of its date, regardless of the time of delivery of this prospectus or any amendment or supplement to this prospectus, as applicable, or any sale of the securities offered by this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date. For Investors Outside the United States: The Selling Stockholder is offering to sell, and seeking offers to buy, the securities offered by this prospectus only in jurisdictions where offers and sales are permitted. Neither we nor the Selling Stockholder have done anything that would permit this offering or the possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the securities offered by this prospectus and the distribution of this prospectus outside the United States. i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement that we filed with the SEC. The Selling Stockholder m

View Full Filing

View this S-1 filing on SEC EDGAR